Clinical Trials Logo

Cesarean Section; Infection clinical trials

View clinical trials related to Cesarean Section; Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06119113 Completed - Scar Clinical Trials

Wound Infection Due to Suture Material in Caesarean Skin Incision and Evaluation of Cosmetic Results

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Our primary aim is to determine the most beneficial suture in order to reduce complications due to skin incision in common surgeries such as cesarean section, and our secondary aim is to evaluate the suture material used in terms of cosmetic results and participant preference.

NCT ID: NCT05807633 Completed - Clinical trials for Cesarean Section Complications

Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section

SCOTT
Start date: June 15, 2022
Phase:
Study type: Observational

The aim of this study is to collect clinical data on the use of Novosyn® applied for the uterus closure in cesarean section. Diverse parameters have been selected to assess that the safety and effectiveness of Novosyn® is comparable to published results, where the rate of SSIs in patients undergoing uterus closure in cesarean section was 10.6%.

NCT ID: NCT05330650 Completed - Clinical trials for Cesarean Section; Infection

Evaluation of Triclosan Coated Suture in Obstetrical Surgery

Start date: November 1, 2020
Phase: Phase 4
Study type: Interventional

A prospective comparative randomized blinded study conducted in the obstetrics gynecology department of Ben Arous hospital over an eight-month period between November 2020 and June 2021. The aim of this study is to evaluate effectiveness of Triclosan coated suture use in obstetrical surgery.

NCT ID: NCT04587960 Completed - Clinical trials for Cesarean Section; Infection

Delayed Primary Closure of Skin in Emergency Caesarean Section

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.

NCT ID: NCT04365452 Completed - Clinical trials for Cesarean Section; Infection

The Invia Motion at Cesarean Study

Start date: March 10, 2020
Phase: Phase 4
Study type: Interventional

To assess patient centered outcomes of the Medela INVIA Motion prophylactic NPWT system at cesarean delivery.

NCT ID: NCT03838965 Completed - Preeclampsia Clinical Trials

The Effects of Labor Stages and Interventions on Hemodynamic Measures During & After Childbirth With Noninvasive Sensors

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The Effects of Labor Stages and Interventions on Hemodynamic Measures During and After Childbirth ( Epidural, Rupture Membranses Cesarean Sections and Preeclampsia) With Noninvasive Sensors.

NCT ID: NCT03640507 Completed - Clinical trials for Surgical Site Infection

Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline

Start date: October 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.

NCT ID: NCT03536832 Completed - Clinical trials for Cesarean Section; Infection

Subcuticular Skin Closure at Cesarean Delivery

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

Subcuticular skin closure with suture after cesarean has been shown to result in lower rates of wound complications than with staple closure. However, the optimal choice of suture material for subcuticular skin closure is unclear. Vicryl vs Prolen suture materials will be used for subcuticular closure of transverse skin incisions after cesarean section. Patients will be controlled for superficial surgical site infections 1 week after the cesarean section.

NCT ID: NCT03284749 Completed - Clinical trials for Surgical Site Infection

Effect of Copper on the Healing of Obstetric Wounds

ECHO
Start date: January 14, 2016
Phase: N/A
Study type: Interventional

The most common complication of vaginal delivery is perineal tearing with a prevalence of 85% and 70% will need suturing. The caesarean section rate worldwide is rising and the rate in Croydon University Hospital is in the region of 25% of all deliveries. One in ten women will develop a wound infection of their perineal tear or caesarean section wound. Wound infection can cause pain, dehiscence, delayed wound healing, prolonged hospital stay, readmissions and interfere with a woman's ability to nurture their baby and enjoy motherhood. Copper has shown to have strong antimicrobial properties, with the ability to kill various bacteria including MRSA. It has also been shown that copper promotes new blood vessel formation and therefore enhance wound healing. This study is to investigate the effect of copper impregnated dressings and maternity pads on wound infection. Women will be randomised for a wound dressing or maternity pad with (study group) or without copper (control group). Both the clinician and the woman will be blinded to the randomised group. Wound infection will be assessed via a telephone questionnaire after 7, 14 and 30 days after delivery. When wound infection is suspected, based on the questionnaire, a swab of the wound site will be taken to detect the causative bacteria.